Inappropriate Suppression of Thyrotropin Concentrations in Young Patients with Thyroid Nodules Including Thyroid Cancer: The Fukushima Health Management Survey

Thyroid

Volumn 26, Issue 5, 2016, Pages 717-725

  Suzuki, Satoru ^a   Nakamura, Izumi ^a   Suzuki, Satoshi ^a   Ohkouchi, Chiyo ^a   Mizunuma, Hiroshi ^a   Midorikawa, Sanae ^a   Fukushima, Toshihiko ^a   Ito, Yuko ^a   Shimura, Hiroki ^a   Ohira, Tetsuya ^a   Matsuzuka, Takashi ^a   Ohtsuru, Akira ^a   Abe, Masafumi ^a   Yamashita, Shunichi ^a   Suzuki, Shinichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; LIOTHYRONINE; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; ECHOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; FUKUSHIMA NUCLEAR ACCIDENT; HEALTH CARE MANAGEMENT; HEALTH CARE SURVEY; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID FUNCTION TEST; THYROID NODULE; THYROTROPIN BLOOD LEVEL; AGE; BLOOD; CHILD; DIAGNOSTIC IMAGING; PRESCHOOL CHILD; THYROID GLAND; THYROID TUMOR; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMANS; THYROID FUNCTION TESTS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84968853495     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2015.0499     Document Type: Article

References (23)

1. Yasumura S, Hosoya M, Yamashita S, Kamiya K, Abe M, Akashi M, Kodama K, Ozasa K, Fukushima Health Management Survey Group 2012 Study protocol for the Fukushima Health Management Survey. J Epidemiol 22: 375-383.
2. Japan Association of Breast and Thyroid Sonology Committee for Thyroidal Terminology and Diagnostic Criteria 2012 Diagnosis for thyroid lesions. In: Thyroid Ultrasound-A Guidebook for Diagnosis and Management. Second edition. Nankodo, Tokyo, pp 25-29. [In Japanese].
3. Iwaku K, Noh JY, Minagawa A, Kosuga Y, Suzuki M, Sekiya K, Matsumoto M, Ohye H, Kunii Y, Yoshihara A, Watanabe N, Mukasa K, Ito K, Ito K 2013 Determination of pediatric reference levels of fT3, fT4 and TSH measured with ECLusys kits. Endocr J 60:799-804.
4. Burrow GN, Fisher DA, Larsen PR 1994 Maternal and fetal thyroid function. N Engl J Med 331:1072-1078.
5. de Escobar GM, Ares S, Berbel P, Obregón MJ, del Rey FE 2008 The changing role of maternal thyroid hormone in fetal brain development. Semin Perinatol 32:380-386.
6. Salvatore D, Davies T, Schlumberger MJ, Hay JD, Larsen PR 2011 Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology. 12th edition. Saunders, Philadelphia, PA, pp 327-361.
7. Medici M, Visser WE, Visser TJ, Peeters RP 2015 Genetic determination of the hypothalamic-pituitary-thyroid axis: where do we stand? Endocr Rev 36:214-244.
8. Suzuki S, Nishio S, Takeda T, Komatsu M 2012 Genderspecific regulation of response to thyroid hormone in aging. Thyroid Res 5:1.
9. Boelen A, Kwakkel J, Fliers E 2011 Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev 32:670-693.
10. Van den Berghe G 2014 Non-thyroidal illness in the ICU: A syndrome with different faces. Thyroid 24:1456-1465.
11. Niedziela M 2014 Thyroid nodules. Best Pract Res Clin Endocrinol Metab 28:245-277.
12. McLeod DS 2014 Thyrotropin in the development and management of differentiated thyroid cancer. Endocrinol Metab Clin North Am 43:367-383.
13. Mussa A, Salerno MC, Bona G, Wasniewska M, Segni M, Cassio A, Vigone MC, Gastaldi R, Iughetti L, Santanera A, Capalbo D, Matarazzo P, De Luca F, Weber G, Corrias A 2013 Serum thyrotropin concentration in children with isolated thyroid nodules. J Pediatr 163:1465-1470.
14. Fiore E, Vitti P 2012 Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab 97:1134-1145.
15. McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL 2012 Thyrotropin and thyroid cancer diagnosis: A systematic review and dose-response metaanalysis. J Clin Endocrinol Metab 97:2682-2692.
16. Papaleontiou M, Haymart MR 2014 New insights in risk stratification of differentiated thyroid cancer. Curr Opin Oncol 26:1-7.
17. Sohn SY, Kim HJ, Jang HW, Kim SW, Chung JH 2014 Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas. Head Neck 36:43-46.
18. Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Østergaard JN, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, PalliD,Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quirós JR, Agudo A, Molina E, Larrañaga N, Navarro C, Ardanaz E, Manjer J, Almquist M, SandströmM, Hennings J,KhawKT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, GunterM, Riboli E, Franceschi S 2014 Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: The EPIC study. J Natl Cancer Inst 106:dju097.
19. Aggarwal N, Razvi S 2013 Thyroid and aging or the aging thyroid? An evidence-based analysis of the literature. J Thyroid Res 2013:481287.
20. Shimura H, Suzuki S, Fukushima T, Midorikawa S, Nakano K, Ito Y, Ohira T, Yamashita S, Suzuki S 2015 Reference intervals of thyroid function tests and prevalence of thyroid function disorders in children and adolescents with thyroid nodules: The Fukushima Health Management Survey. Program of the Annual Meeting of the Endocrine Society, San Diego, CA (abstract Fri-012).
21. Ahn D, Sohn JH, Jeon JH, Park J 2014 Preoperative subclinical hyperthyroidism in patients with papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 7:312-318.
22. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.
23. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Helgadottir HT, Li W, Nagy R, Ringel MD, Kloos RT, de Visser MC, Plantinga TS, den Heijer M, Aguillo E, Panadero A, Prats E, Garcia-Castaño A, De Juan A, Rivera F, Walters GB, Bjarnason H, Tryggvadottir L, Eyjolfsson GI, Bjornsdottir US, Holm H, Olafsson I, Kristjansson K, Kristvinsson H, Magnusson OT, Thorleifsson G, Gulcher JR, Kong A, Kiemeney LA, Jonsson T, Hjartarson H, Mayordomo JI, Netea-Maier RT, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Rafnar T, Stefansson K 2012 Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 44:319-322.